In a separate study, an 8-week treatment with MSTN antibodies in rats exhibited protective effects against the detrimental impacts of T2DM on femoral microstructure and the corresponding reduction in mechanical strength [66]. The gene discussed is MSTN; the disease is type 2 diabetes mellitus.